oncology research Archives

Technology Is Rapidly Changing Cancer Care

Technology Is Rapidly Changing Cancer Care

By Nick Bergh|2021-01-25T15:46:12+00:00January 25th, 2021|

By Sai Balasubramanian, J.D., Forbes

Lantern Pharma Announces Scientific & Preclinical Data Indicating Blood Brain Permeability for Drug Candidate LP-184 in Glioblastoma and Potentially Other CNS Cancers

By Nick Bergh|2020-12-15T16:52:47+00:00December 15th, 2020|

Lantern Pharma Announces Scientific & Preclinical Data Indicating Blood Brain Permeability for Drug Candidate LP-184 in Glioblastoma and Potentially Other CNS Cancers Dec 15, 2020, 07:00 ET Read on Cision PR Newswire LP-184 preclinical studies reinforce the drug compound’s potential to effectively cross the blood-brain barrier with significant potency Continued progress in advancing glioblastoma [...]

> Read More

Lantern Pharma’s A.I. Platform Is Helping To Transform The Probability Of Success In Oncology Drug Development & Clinical Trials

Lantern Pharma’s A.I. Platform Is Helping To Transform The Probability Of Success In Oncology Drug Development & Clinical Trials

By Nick Bergh|2020-12-10T16:21:37+00:00December 8th, 2020|

By Jaycee Tenn, Benzinga

> Read More

Lantern Pharma AI milestone will cut cost, time and risk in developing new drug therapies

Lantern Pharma AI milestone will cut cost, time and risk in developing new drug therapies

By Nick Bergh|2020-11-19T16:06:43+00:00November 19th, 2020|

By Drug Discovery World

> Read More

Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development

Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development

By Nick Bergh|2020-11-19T16:06:55+00:00November 18th, 2020|

By Alex Edwards, Dallas Innovates

> Read More

Episode 68: Rocking Garage Biotech

Episode 68: Rocking Garage Biotech

By Nick Bergh|2021-07-27T19:47:04+00:00October 29th, 2020|

By Elaine Quilici, PharmExec.com

> Read More

Lantern Pharma applying AI to discover and develop cancer therapeutics

Lantern Pharma applying AI to discover and develop cancer therapeutics

By Nick Bergh|2020-10-13T19:09:10+00:00October 13th, 2020|

By Abby Hardy, BioTuesdays

> Read More

Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown University for LP-184, a Next-Generation, Targeted DNA-Damaging Agent

By Nick Bergh|2020-10-05T15:46:33+00:00October 5th, 2020|

Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown University for LP-184, a Next-Generation, Targeted DNA-Damaging AgentOct 05, 2020, 07:46 ETRead on Cision PR NewswireDALLAS, Oct. 5, 2020 /PRNewswire/ -- Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery and development, and identify patients who will benefit [...]

> Read More